MedTrace Logo

Study On Let's Talk

NCT07246083 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2026-01-15

No results posted yet for this study

Summary

The goal of this experience sampling method study is to understand the effectiveness and user experience of the 'let's talk' forum-- a public platform designed by the Ministry of Health Office for Healthcare Transformation (MOHT) to provide just-in-time digital mental health support for youths. 'Let's Talk' is a joint initiative by MOHT, Ministry of Social and Family Development (MSF), National Council of Social Service (NCSS), and the Institute of Mental Health (IMH) in Singapore.

Participants who meet the eligibility criteria (based on DASS-21 cutoff scores) will be invited to participate in Phase 2, which involves a 21-day intervention period involving the 'let's talk' forum. The experience sampling protocol involves sending prompts at regular intervals and monitoring anxiety levels.

Conditions

  • Mental Health Help-Seeking

Interventions

BEHAVIORAL

let's talk forum

The platform also features an "Ask-a-Therapist" function, allowing users to anonymously pose questions to a panel of verified psychotherapists and receive a response within 24 hours. As such, Let's Talk provides a valuable case study to: * assess the real-time impact of digital peer support and professional input, and * explore how anonymous online interactions may support emotion regulation and enhance well-being

Sponsors & Collaborators

  • MOH Office for Healthcare Transformation (MOHT), Singapore

    collaborator UNKNOWN

  • Centre for Evidence and Implementation Singapore Ltd

    lead OTHER

Principal Investigators

  • Jean Liu · Centre for Evidence and Implementation

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-18
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07246083 on ClinicalTrials.gov